AC IMMUNE SA - Switzerland 

Ranking results:

Past rankings:

Subject specific rankings are not yet available..

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 3.757.318 238.461 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN2
ALZHEIMER EUROPE2
F HOFFMANNLA ROCHE2
GOETEBORGS UNIVERSITET2
JANSSEN PHARMACEUTICA NV2
KING'S COLLEGE LONDON2
NOVARTIS PHARMA2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITEIT MAASTRICHT2
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACADEMISCH ZIEKENHUIS LEIDEN1
ARIDHIA INFORMATICS LIMITED1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOGEN IDEC LIMITED1
BMD SOFTWARE LDA1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO1
CHU HOPITAUX DE BORDEAUX1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
EATRIS ERIC1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ELI LILLY AND COMPANY LIMITED1
ENKAM PHARMACEUTICALS1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
GATES VENTURES LLC1
GE HEALTHCARE LIMITED1
H LUNDBECK1
H LUNDBECK AS1
INSTITUT CURIE1
IXICO TECHNOLOGIES LIMITED1
KAROLINSKA INSTITUTE1
KOBENHAVNS UNIVERSITET1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
LUNDS UNIVERSITET1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NSGENE1
RIJKSUNIVERSITEIT GRONINGEN1
SANOFIAVENTIS1
SIENA BIOTECH1
STICHTING LYGATURE1
STICHTING VUMC1
SVAR LIFE SCIENCE AB1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE UNIVERSITY OF EDINBURGH1
UCB BIOPHARMA1
UNIVERSITE DE GENEVE1
UNIVERSITE DE PARIS VII DENIS DIDEROT1
UNIVERSITE DU LUXEMBOURG1
UNIVERSITY OF AARHUS1
UNIVERSITY OF LEICESTER1

Constancy:

Total number of partners: 68
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 68
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2011-03-01TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases TreatPolyQparticipant3.757.31816

Alias institution names:

  • AC IMMUNE